share_log

一品红(300723.SZ):全资子公司一类创新药APH01727片获得临床试验注册申请受理的

Poinsettia (300723.SZ): A wholly-owned subsidiary, the first-class innovative drug APH01727 tablets were accepted for clinical trial registration

Gelonghui Finance ·  May 13 23:51

Gelonghui, May 14, 丨 Yipinhong (300723.SZ) announced that recently, the drug clinical trial application for APH01727 tablets, a class of innovative drugs independently developed by Guangzhou Yipinhong Pharmaceutical Co., Ltd. (hereinafter referred to as “Yipinhong Pharmaceutical”), a wholly-owned subsidiary of the company, was accepted by the China Drug Administration and received a “Notice of Acceptance”.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment